Relax Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Relax Pharmaceuticals: trust score, financial health, credit view, compliance, directors, growth and distress …

1997-07-31 Saharanpur, Uttar Pradesh Active Unlisted Active Compliant
Share
Connect MCP
RP Relax Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Relax Pharmaceuticals — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Relax Pharmaceuticals is assessed as Low Risk with a Trust Score of 77/100. Relax Pharmaceuticals is an active private limited indian non-government company incorporated in 1997, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 02 Aug 2026 from the latest processed filings. Relax Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (51.38 cr) · 6 satisfied (23.10 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Hdfc Bank Limited2 48.0 cr
State Bank Of Patiala1 48.0 cr
Member Secretory Single Window Clearance Agency1 48.0 cr
State Bank Of Patiyala1 48.0 cr
Ditrict Industries Centre1 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 auditor resignation(s) filed - latest: Gupta Shiv & Co. on 2019-03-04.
  • Delayed payments to MSME suppliers disclosed (474 disclosure(s)).
  • 3 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
ABHAY KUMAR SRIVASTAVA 01234567 Director 01/04/2018 6 yrs Approved
AKHLAS AHMED 01234567 Director 01/04/2018 6 yrs Approved
VEER SINGH PAL 01234567 Director 01/04/2018 6 yrs Approved
Vikash Sharma 01234567 Director 01/04/2018 6 yrs Approved
BHUPENDRA KAUSHIK 01234567 Director 01/04/2018 6 yrs Approved
ANJU KUMARI JHA 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Mankind Pharma Limited
Subsidiaries
1
Group entities
1
Capital events
0 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Qualitek Starch Private Limited Subsidiary Company 74.00%
Mankind Pharma Limited Holding Company 74.00%

Key managerial personnel: Vikash Sharma (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Operating for 29+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 5.99 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 51.38 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
27 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Oct 2024
Charge created
Others - 50.00 cr
08 Aug 2024
Director appointed
Vikash Sharma (Whole-time director)
Director ceased
Vikash Sharma
27 Nov 2021
Director ceased
ABHAY KUMAR SRIVASTAVA
Director ceased
AKHLAS AHMED
Director ceased
BHUPENDRA KAUSHIK
Director ceased
ANJU KUMARI JHA
17 Apr 2021
Charge created
Others - 1.38 cr
26 Mar 2021
Director appointed
BHUPENDRA KAUSHIK (Director)
Director appointed
ANJU KUMARI JHA (Director)
25 Mar 2021
Director ceased
VEER SINGH PAL
01 Mar 2021
Director appointed
ABHAY KUMAR SRIVASTAVA (Director)
Director appointed
AKHLAS AHMED (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
6 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Shree Chlorates Private Limited U31200MP1987PTC003806 Indore., Madhya Pradesh, India
Aks Expo-Chem Private Limited U51101DL2007PTC163409 New Delhi, Delhi, India
Indo Brine Industries Limited U51100GJ1996PLC031160 Ahmedabad, Gujarat, India
Spansules Formulations India Private Limited U24230TG2022PTC160441 Hyderabad, Telangana, India
Mineralstech U27109MH2006FTC163543 Thane West, Maharashtra, India
Noble Alchem Private Limited U74899DL1999PTC101897 Delhi, Delhi, India
Jmitra U52110DL1969PTC005010 New Delhi, Delhi, India
Sbl U24231CH1994PTC015100 Chandigarh, Chandigarh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Relax Pharmaceuticals before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Relax Pharmaceuticals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Relax Pharmaceuticals - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Relax Pharmaceuticals pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Relax Pharmaceuticals - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Relax Pharmaceuticals an active company?

Relax Pharmaceuticals has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Relax Pharmaceuticals financially healthy?

Relax Pharmaceuticals has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Relax Pharmaceuticals?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Relax Pharmaceuticals?

The ultimate holding entity is Mankind Pharma Limited. 6 active director(s) are on record.

Does Relax Pharmaceuticals have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.

Is Relax Pharmaceuticals up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Relax Pharmaceuticals?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.